242 related articles for article (PubMed ID: 14981375)
61. Effectiveness of Lactobacillus-containing vaginal tablets in the treatment of symptomatic bacterial vaginosis.
Mastromarino P; Macchia S; Meggiorini L; Trinchieri V; Mosca L; Perluigi M; Midulla C
Clin Microbiol Infect; 2009 Jan; 15(1):67-74. PubMed ID: 19046169
[TBL] [Abstract][Full Text] [Related]
62. Rate of preterm births in pregnant women with common lower genital tract infection: a population-based study based on the clinical practice.
Bánhidy F; Acs N; Puho EH; Czeizel AE
J Matern Fetal Neonatal Med; 2009 May; 22(5):410-8. PubMed ID: 19529998
[TBL] [Abstract][Full Text] [Related]
63. A pilot study of treatment of bacterial vaginosis with a buffering vaginal microbicide.
Harwell JI; Moench T; Mayer KH; Chapman S; Rodriguez I; Cu-Uvin S
J Womens Health (Larchmt); 2003 Apr; 12(3):255-9. PubMed ID: 12804356
[TBL] [Abstract][Full Text] [Related]
64. Bacterial vaginosis: drugs versus alternative treatment.
Neri A; Rabinerson D; Kaplan B
Obstet Gynecol Surv; 1994 Dec; 49(12):809-13. PubMed ID: 7885656
[TBL] [Abstract][Full Text] [Related]
65. An adherent Gardnerella vaginalis biofilm persists on the vaginal epithelium after standard therapy with oral metronidazole.
Swidsinski A; Mendling W; Loening-Baucke V; Swidsinski S; Dörffel Y; Scholze J; Lochs H; Verstraelen H
Am J Obstet Gynecol; 2008 Jan; 198(1):97.e1-6. PubMed ID: 18005928
[TBL] [Abstract][Full Text] [Related]
66. Fetal fibronectin and bacterial vaginosis are associated with preterm birth in women who are symptomatic for preterm labor.
Stevens AO; Chauhan SP; Magann EF; Martin RW; Bofill JA; Cushman JL; Morrison JC
Am J Obstet Gynecol; 2004 Jun; 190(6):1582-7; discussion 1587-9. PubMed ID: 15284741
[TBL] [Abstract][Full Text] [Related]
67. The effectiveness of live lactobacilli in combination with low dose oestriol (Gynoflor) to restore the vaginal flora after treatment of vaginal infections.
Ozkinay E; Terek MC; Yayci M; Kaiser R; Grob P; Tuncay G
BJOG; 2005 Feb; 112(2):234-40. PubMed ID: 15663590
[TBL] [Abstract][Full Text] [Related]
68. Treatment of recurrent bacterial vaginosis with tinidazole.
Baylson FA; Nyirjesy P; Weitz MV
Obstet Gynecol; 2004 Nov; 104(5 Pt 1):931-2. PubMed ID: 15516381
[TBL] [Abstract][Full Text] [Related]
69. Treatment of bacterial vaginosis.
Schlicht JR
Ann Pharmacother; 1994 Apr; 28(4):483-7. PubMed ID: 8038475
[TBL] [Abstract][Full Text] [Related]
70. The effects of intravaginal clindamycin and metronidazole therapy on vaginal mobiluncus morphotypes in patients with bacterial vaginosis.
Nyirjesy P; McIntosh MJ; Steinmetz JI; Schumacher RJ; Joffrion JL
Sex Transm Dis; 2007 Apr; 34(4):197-202. PubMed ID: 17179772
[TBL] [Abstract][Full Text] [Related]
71. Recurrence of symptomatic bacterial vaginosis 12 months after oral metronidazole therapy in HIV-positive and -negative women.
Myer L; Kuhn L; Denny L; Wright TC
J Infect Dis; 2006 Dec; 194(12):1797-9. PubMed ID: 17109360
[No Abstract] [Full Text] [Related]
72. Asymptomatic bacterial vaginosis: is it time to treat?
Gibbs RS
Am J Obstet Gynecol; 2007 Jun; 196(6):495-6. PubMed ID: 17547871
[No Abstract] [Full Text] [Related]
73. A polymorphism in the promoter region of TNF and bacterial vaginosis: preliminary evidence of gene-environment interaction in the etiology of spontaneous preterm birth.
Macones GA; Parry S; Elkousy M; Clothier B; Ural SH; Strauss JF
Am J Obstet Gynecol; 2004 Jun; 190(6):1504-8; discussion 3A. PubMed ID: 15284722
[TBL] [Abstract][Full Text] [Related]
74. The Women's Health II Medical Education Network _Part 1: Understanding bacterial vaginosis: diagnosis, treatment, and improved outcomes.
Schwebke J
J Fam Pract; 2007 Sep; 56(9 Suppl Women):S1-6; quiz S7-8. PubMed ID: 18667133
[No Abstract] [Full Text] [Related]
75. Prospective validation of a perinatal bacterial vaginosis screening risk score.
Pastore LM; King TS; Dawson IJ; Hollifield A; Thorp JM
J Perinatol; 2004 Dec; 24(12):735-42. PubMed ID: 15306827
[TBL] [Abstract][Full Text] [Related]
76. The association of Atopobium vaginae and Gardnerella vaginalis with bacterial vaginosis and recurrence after oral metronidazole therapy.
Bradshaw CS; Tabrizi SN; Fairley CK; Morton AN; Rudland E; Garland SM
J Infect Dis; 2006 Sep; 194(6):828-36. PubMed ID: 16941351
[TBL] [Abstract][Full Text] [Related]
77. High recurrence rates of bacterial vaginosis over the course of 12 months after oral metronidazole therapy and factors associated with recurrence.
Bradshaw CS; Morton AN; Hocking J; Garland SM; Morris MB; Moss LM; Horvath LB; Kuzevska I; Fairley CK
J Infect Dis; 2006 Jun; 193(11):1478-86. PubMed ID: 16652274
[TBL] [Abstract][Full Text] [Related]
78. Comparison of local metronidazole and a local antiseptic in the treatment of bacterial vaginosis.
Novakov Mikic A; Budakov D
Arch Gynecol Obstet; 2010 Jul; 282(1):43-7. PubMed ID: 19809829
[TBL] [Abstract][Full Text] [Related]
79. Intravaginally applied metronidazole is as effective as orally applied in the treatment of bacterial vaginosis, but exhibits significantly less side effects.
Brandt M; Abels C; May T; Lohmann K; Schmidts-Winkler I; Hoyme UB
Eur J Obstet Gynecol Reprod Biol; 2008 Dec; 141(2):158-62. PubMed ID: 18775597
[TBL] [Abstract][Full Text] [Related]
80. Intravaginal metronidazole gel versus metronidazole plus nystatin ovules for bacterial vaginosis: a randomized controlled trial.
Sanchez S; Garcia PJ; Thomas KK; Catlin M; Holmes KK
Am J Obstet Gynecol; 2004 Dec; 191(6):1898-906. PubMed ID: 15592270
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
